PURA VIDA INVESTMENTS, LLC - Q1 2020 holdings

Add to watchlist

$842 Million is the total value of PURA VIDA INVESTMENTS, LLC's 93 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 93.0% .

All

			Value		Shares		↓ Weighting
SPY	Sell	SPDR S&P 500 ETF TRput	$88,331,000	-43.6%	342,700	-29.5%	10.49%	-23.8%
XLV	Buy	SELECT SECTOR SPDR TRput	$66,701,000	+62.5%	753,000	+86.8%	7.92%	+119.3%
XBI	Buy	SPDR SER TRput	$48,013,000	+17.9%	620,000	+44.9%	5.70%	+59.2%
MDT	Buy	MEDTRONIC PLCcall	$42,836,000	+41.9%	475,000	+78.6%	5.09%	+91.6%
IWM	Buy	ISHARES TRput	$31,911,000	-25.3%	278,800	+8.1%	3.79%	+0.8%
ICUI	Buy	ICU MED INC	$25,581,000	+32.3%	126,784	+22.7%	3.04%	+78.6%
ICUI	Buy	ICU MED INCcall	$24,515,000	+84.5%	121,500	+71.1%	2.91%	+149.0%
FXH	Buy	FIRST TR EXCHANGE TRADED FDput	$24,410,000	+7.8%	330,000	+22.7%	2.90%	+45.5%
INSP	Sell	INSPIRE MED SYS INC	$22,001,000	-22.7%	364,980	-4.9%	2.61%	+4.3%
NSTG	Sell	NANOSTRING TECHNOLOGIES INC	$21,916,000	-18.3%	911,253	-5.5%	2.60%	+10.2%
LLY	New	LILLY ELI & COput	$20,808,000	–	150,000	+100.0%	2.47%	–
ATRC	New	ATRICURE INCcall	$18,978,000	–	565,000	+100.0%	2.25%	–
ALXN	Buy	ALEXION PHARMACEUTICALS INC	$18,676,000	+98.0%	207,996	+138.6%	2.22%	+167.2%
INOV	Buy	INOVALON HLDGS INC	$18,393,000	+38.0%	1,104,040	+55.8%	2.18%	+86.2%
ALXN	New	ALEXION PHARMACEUTICALS INCcall	$17,958,000	–	200,000	+100.0%	2.13%	–
VRAY	Buy	VIEWRAY INC	$17,262,000	-35.6%	6,904,628	+8.7%	2.05%	-13.1%
STAA	Sell	STAAR SURGICAL CO	$15,774,000	-17.0%	488,950	-9.5%	1.87%	+12.1%
OCX	Sell	ONCOCYTE CORP	$13,667,000	+6.6%	5,578,283	-2.1%	1.62%	+43.9%
ATRC	New	ATRICURE INC	$13,066,000	–	388,994	+100.0%	1.55%	–
QQQ	New	INVESCO QQQ TRput	$12,852,000	–	67,500	+100.0%	1.53%	–
ESTA	Buy	ESTABLISHMENT LABS HLDGS INC	$12,690,000	-32.8%	878,227	+28.7%	1.51%	-9.3%
SRPT	Buy	SAREPTA THERAPEUTICS INCput	$12,658,000	-10.0%	129,400	+18.7%	1.50%	+21.5%
ABMD	Sell	ABIOMED INCput	$12,440,000	-58.8%	85,700	-51.6%	1.48%	-44.4%
IVC	Buy	INVACARE CORP	$11,946,000	-1.1%	1,607,846	+20.1%	1.42%	+33.6%
ZBH	Sell	ZIMMER BIOMET HOLDINGS INC	$11,205,000	-42.8%	110,852	-15.2%	1.33%	-22.7%
DXCM	Sell	DEXCOM INC	$10,012,000	-16.9%	37,183	-32.5%	1.19%	+12.2%
RCM	Buy	R1 RCM INC	$9,762,000	-7.1%	1,073,943	+32.6%	1.16%	+25.4%
XENT	Sell	INTERSECT ENT INC	$8,080,000	-55.6%	681,865	-6.6%	0.96%	-40.1%
INOV	Buy	INOVALON HLDGS INCcall	$7,914,000	+285.9%	475,000	+335.8%	0.94%	+422.2%
TMO	New	THERMO FISHER SCIENTIFIC INCput	$7,799,000	–	27,500	+100.0%	0.93%	–
XLRN	New	ACCELERON PHARMA INC	$6,891,000	–	76,681	+100.0%	0.82%	–
MNTA	Buy	MOMENTA PHARMACEUTICALS INC	$6,697,000	+107.6%	246,214	+50.6%	0.80%	+179.9%
QTNT	Buy	QUOTIENT LTD	$6,639,000	-36.0%	1,680,641	+54.1%	0.79%	-13.6%
MTUM	New	ISHARES TRput	$6,389,000	–	60,000	+100.0%	0.76%	–
SIBN	New	SI BONE INC	$6,172,000	–	516,476	+100.0%	0.73%	–
KIDS	Sell	ORTHOPEDIATRICS CORP	$5,887,000	-48.5%	148,513	-39.0%	0.70%	-30.5%
CPRX	New	CATALYST PHARMACEUTICALS INC	$5,571,000	–	1,446,953	+100.0%	0.66%	–
REGN	New	REGENERON PHARMACEUTICALS	$5,475,000	–	11,212	+100.0%	0.65%	–
ADPT	Buy	ADAPTIVE BIOTECHNOLOGIES COR	$5,417,000	+235.2%	195,000	+261.0%	0.64%	+352.8%
VAR	New	VARIAN MED SYS INCput	$5,390,000	–	52,500	+100.0%	0.64%	–
PROF	New	PROFOUND MED CORP	$5,282,000	–	542,256	+100.0%	0.63%	–
TWST	New	TWIST BIOSCIENCE CORP	$5,280,000	–	172,670	+100.0%	0.63%	–
QDEL	New	QUIDEL CORP	$5,086,000	–	51,999	+100.0%	0.60%	–
SRPT	New	SAREPTA THERAPEUTICS INCcall	$4,891,000	–	50,000	+100.0%	0.58%	–
GILD	New	GILEAD SCIENCES INCcall	$4,112,000	–	55,000	+100.0%	0.49%	–
BSX	New	BOSTON SCIENTIFIC CORP	$4,079,000	–	125,000	+100.0%	0.48%	–
AVDL	Buy	AVADEL PHARMACEUTICALS PLCsponsored adr	$3,943,000	+379.1%	496,660	+355.7%	0.47%	+550.0%
KALA	New	KALA PHARMACEUTICALS INCput	$3,839,000	–	436,700	+100.0%	0.46%	–
GH	Sell	GUARDANT HEALTH INC	$3,791,000	-19.1%	54,475	-9.1%	0.45%	+9.2%
GILD	New	GILEAD SCIENCES INC	$3,738,000	–	50,000	+100.0%	0.44%	–
NVCR	New	NOVOCURE LTDcall	$3,663,000	–	54,400	+100.0%	0.44%	–
PPD	New	PPD INC	$3,651,000	–	205,000	+100.0%	0.43%	–
	New	DERMTECH INC	$3,475,000	–	308,916	+100.0%	0.41%	–
TXG	Sell	10X GENOMICS INC	$3,404,000	-48.9%	54,620	-37.5%	0.40%	-31.1%
CSTL	New	CASTLE BIOSCIENCES INC	$3,306,000	–	110,899	+100.0%	0.39%	–
	New	CYTOKINETICS INCnote 4.000%11/1	$3,304,000	–	25,000	+100.0%	0.39%	–
CERS	New	CERUS CORP	$3,145,000	–	676,321	+100.0%	0.37%	–
STXS	Buy	STEREOTAXIS INC	$3,108,000	+140.7%	1,029,281	+321.7%	0.37%	+223.7%
MSON	New	MISONIX INC	$3,014,000	–	320,000	+100.0%	0.36%	–
IMVTU	Buy	IMMUNOVANT INCunit 12/18/2024	$2,895,000	-28.5%	175,010	+6.0%	0.34%	-3.4%
APYX	Buy	APYX MEDICAL CORPORATION	$2,522,000	-48.0%	702,449	+22.4%	0.30%	-30.0%
OTIC	Buy	OTONOMY INC	$2,456,000	-43.8%	1,246,858	+9.4%	0.29%	-24.0%
AMRN	Buy	AMARIN CORP PLCspons adr new	$2,425,000	+227.7%	606,320	+1657.4%	0.29%	+343.1%
IMMU	Sell	IMMUNOMEDICS INCput	$2,232,000	-51.6%	165,600	-24.0%	0.26%	-34.7%
AMRN	Sell	AMARIN CORP PLCput	$2,070,000	-85.2%	517,600	-20.9%	0.25%	-80.1%
NVRO	New	NEVRO CORP	$2,000,000	–	20,000	+100.0%	0.24%	–
ARDX	Buy	ARDELYX INC	$1,840,000	-10.1%	323,641	+18.7%	0.22%	+21.1%
ITMR	New	ITAMAR MED LTDsponsored ads	$1,802,000	–	152,947	+100.0%	0.21%	–
TGTX	Sell	TG THERAPEUTICS INC	$1,761,000	-42.9%	178,964	-35.5%	0.21%	-22.9%
SELB	New	SELECTA BIOSCIENCES INC	$1,506,000	–	624,755	+100.0%	0.18%	–
OSUR	New	ORASURE TECHNOLOGIES INC	$1,453,000	–	135,021	+100.0%	0.17%	–
AUPH	Sell	AURINIA PHARMACEUTICALS INC	$1,435,000	-73.5%	98,913	-63.0%	0.17%	-64.3%
NLTX	Sell	NEOLEUKIN THERAPEUTICS INC	$1,108,000	-29.8%	97,397	-24.0%	0.13%	-5.0%
ZBH	Sell	ZIMMER BIOMET HOLDINGS INCcall	$1,011,000	-89.8%	10,000	-84.8%	0.12%	-86.2%
HZNP	New	HORIZON THERAPEUTICS PUB L	$972,000	–	32,816	+100.0%	0.12%	–
GNLN		GREENLANE HLDGS INCcl a	$944,000	-47.2%	549,017	0.0%	0.11%	-28.7%
CRBP	New	CORBUS PHARMACEUTICALS HLDGScall	$890,000	–	169,900	+100.0%	0.11%	–
BMYRT	New	BRISTOL-MYERS SQUIBB COright 99/99/9999	$755,000	–	198,740	+100.0%	0.09%	–
SRACU	Sell	STABLE RD ACQUISITION CORPunit 05/15/2026	$744,000	-83.4%	74,070	-83.0%	0.09%	-77.7%
SVRA	Buy	SAVARA INC	$723,000	-43.8%	340,868	+18.7%	0.09%	-23.9%
AGTC	New	APPLIED GENETIC TECHNOLOGIES	$680,000	–	207,358	+100.0%	0.08%	–
MLND	New	MILLENDO THERAPEUTICS INCcall	$676,000	–	128,000	+100.0%	0.08%	–
CRBP	New	CORBUS PHARMACEUTICALS HLDGS	$629,000	–	120,000	+100.0%	0.08%	–
EOLS	Sell	EVOLUS INC	$587,000	-75.3%	141,442	-27.7%	0.07%	-66.5%
AXSM	New	AXSOME THERAPEUTICS INCcall	$588,000	–	10,000	+100.0%	0.07%	–
PBYI	New	PUMA BIOTECHNOLOGY INC	$540,000	–	64,000	+100.0%	0.06%	–
EOLS	New	EVOLUS INCcall	$531,000	–	128,000	+100.0%	0.06%	–
CBAY	Buy	CYMABAY THERAPEUTICS INCcall	$524,000	-18.3%	354,000	+8.3%	0.06%	+10.7%
ABEO	Sell	ABEONA THERAPEUTICS INC	$391,000	-51.2%	186,350	-24.0%	0.05%	-35.2%
	New	TRILLIUM THERAPEUTICS INC	$390,000	–	96,487	+100.0%	0.05%	–
SRRA	New	SIERRA ONCOLOGY INC	$186,000	–	18,940	+100.0%	0.02%	–
	New	CATABASIS PHARMACEUTICALS IN	$75,000	–	18,110	+100.0%	0.01%	–
SSPKW		SILVER SPIKE ACQUISITION COR*w exp 08/02/202	$12,000	-40.0%	50,000	0.0%	0.00%	-50.0%
HEXO	Exit	HEXO CORPput	$0	–	-150,000	-100.0%	-0.02%	–
APLT	Exit	APPLIED THERAPEUTICS INC	$0	–	-21,810	-100.0%	-0.05%	–
SPPI	Exit	SPECTRUM PHARMACEUTICALS INCcall	$0	–	-218,000	-100.0%	-0.07%	–
ALKS	Exit	ALKERMES PLC	$0	–	-54,000	-100.0%	-0.10%	–
QURE	Exit	UNIQURE NV	$0	–	-16,350	-100.0%	-0.10%	–
NVAX	Exit	NOVAVAX INCcall	$0	–	-327,800	-100.0%	-0.12%	–
DERM	Exit	DERMIRA INC	$0	–	-110,350	-100.0%	-0.15%	–
NTRA	Exit	NATERA INCcall	$0	–	-54,000	-100.0%	-0.16%	–
KALA	Exit	KALA PHARMACEUTICALS INC	$0	–	-533,287	-100.0%	-0.17%	–
RCM	Exit	R1 RCM INCcall	$0	–	-163,000	-100.0%	-0.19%	–
CABA	Exit	CABALETTA BIO INC	$0	–	-154,792	-100.0%	-0.19%	–
RCKT	Exit	ROCKET PHARMACEUTICALS INC	$0	–	-109,000	-100.0%	-0.22%	–
NTRA	Exit	NATERA INC	$0	–	-76,300	-100.0%	-0.23%	–
IOVA	Exit	IOVANCE BIOTHERAPEUTICS INCcall	$0	–	-109,000	-100.0%	-0.26%	–
HCA	Exit	HCA HEALTHCARE INCput	$0	–	-22,000	-100.0%	-0.29%	–
FLDM	Exit	FLUIDIGM CORP DEL	$0	–	-1,090,830	-100.0%	-0.33%	–
MASI	Exit	MASIMO CORP	$0	–	-24,409	-100.0%	-0.34%	–
HZNP	Exit	HORIZON THERAPEUTICS PUB Lcall	$0	–	-109,000	-100.0%	-0.35%	–
BYND	Exit	BEYOND MEAT INCput	$0	–	-54,000	-100.0%	-0.36%	–
QGEN	Exit	QIAGEN NV	$0	–	-124,780	-100.0%	-0.37%	–
MMSI	Exit	MERIT MED SYS INCcall	$0	–	-142,000	-100.0%	-0.39%	–
CI	Exit	CIGNA CORP NEWput	$0	–	-22,000	-100.0%	-0.40%	–
AXNX	Exit	AXONICS MODULATION TECHNOLOG	$0	–	-163,490	-100.0%	-0.40%	–
EXAS	Exit	EXACT SCIENCES CORPput	$0	–	-50,000	-100.0%	-0.41%	–
MJ	Exit	ETF MANAGERS TRcall	$0	–	-300,000	-100.0%	-0.45%	–
GH	Exit	GUARDANT HEALTH INCcall	$0	–	-66,000	-100.0%	-0.45%	–
CNMD	Exit	CONMED CORP	$0	–	-46,330	-100.0%	-0.46%	–
CGC	Exit	CANOPY GROWTH CORPput	$0	–	-300,000	-100.0%	-0.56%	–
OMCL	Exit	OMNICELL COMput	$0	–	-79,000	-100.0%	-0.57%	–
SDC	Exit	SMILEDIRECTCLUB INCput	$0	–	-820,000	-100.0%	-0.63%	–
GKOS	Exit	GLAUKOS CORPput	$0	–	-132,000	-100.0%	-0.63%	–
BCRX	Exit	BIOCRYST PHARMACEUTICALS INC	$0	–	-2,179,950	-100.0%	-0.66%	–
DVA	Exit	DAVITA INCput	$0	–	-112,000	-100.0%	-0.74%	–
PKI	Exit	PERKINELMER INCput	$0	–	-94,000	-100.0%	-0.80%	–
CSII	Exit	CARDIOVASCULAR SYS INC DELput	$0	–	-218,000	-100.0%	-0.93%	–
NVRO	Exit	NEVRO CORPcall	$0	–	-92,000	-100.0%	-0.95%	–
QGEN	Exit	QIAGEN NVput	$0	–	-327,000	-100.0%	-0.97%	–
STAA	Exit	STAAR SURGICAL COput	$0	–	-327,000	-100.0%	-1.01%	–
ABT	Exit	ABBOTT LABSput	$0	–	-137,000	-100.0%	-1.05%	–
INSP	Exit	INSPIRE MED SYS INCcall	$0	–	-163,000	-100.0%	-1.06%	–
AGN	Exit	ALLERGAN PLC	$0	–	-69,750	-100.0%	-1.17%	–
GRFS	Exit	GRIFOLS S Asp adr rep b nvt	$0	–	-578,620	-100.0%	-1.18%	–
XENT	Exit	INTERSECT ENT INCcall	$0	–	-654,000	-100.0%	-1.43%	–
BAX	Exit	BAXTER INTL INCcall	$0	–	-205,500	-100.0%	-1.51%	–
ILMN	Exit	ILLUMINA INCcall	$0	–	-52,000	-100.0%	-1.52%	–
BHVN	Exit	BIOHAVEN PHARMACTL HLDG CO Lcall	$0	–	-327,000	-100.0%	-1.57%	–
NSTG	Exit	NANOSTRING TECHNOLOGIES INCcall	$0	–	-654,000	-100.0%	-1.60%	–
QGEN	Exit	QIAGEN NVcall	$0	–	-593,000	-100.0%	-1.76%	–
UNH	Exit	UNITEDHEALTH GROUP INCput	$0	–	-94,000	-100.0%	-2.43%	–
IHI	Exit	ISHARES TRput	$0	–	-109,000	-100.0%	-2.54%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR/A filed 2021-02-12

Signatures

The EDGAR filing(s) were signed by:

Alyssa Romano — Chief Compliance Officer and Chief Financial Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
ICU MED INC	26	Q2 2023	4.2%
NANOSTRING TECHNOLOGIES INC	26	Q2 2023	3.3%
VIEWRAY INC	25	Q2 2023	3.2%
LIVANOVA PLC	23	Q3 2023	3.8%
ALEXION PHARMACEUTICALS INC	23	Q1 2021	4.3%
INSPIRE MED SYS INC	22	Q3 2023	3.7%
BOSTON SCIENTIFIC CORP	22	Q3 2022	4.8%
INVACARE CORP	22	Q3 2021	2.8%
ESTABLISHMENT LABS HLDGS INC	21	Q3 2023	5.0%
INTERSECT ENT INC	21	Q2 2021	2.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

PURA VIDA INVESTMENTS, LLC Q1 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Stryve Foods Holdings, LLC	April 19, 2023	1,470,649	5.6%
ICAD INC	March 15, 2023	1,277,214	5.0%
ESTABLISHMENT LABS HOLDINGS INC.	February 14, 2023	1,002,767	4.1%
Pulmonx Corp	February 14, 2023	1,216,258	3.2%
Quotient Ltd^{Sold out}	February 14, 2023	0	0.0%
Universe Pharmaceuticals INC^{Sold out}	February 14, 2023	0	0.0%
MedMen Enterprises, Inc.	April 29, 2022	139,755,072	21.4%
INVACARE CORP^{Sold out}	February 14, 2022	0	0.0%
MedAvail Holdings, Inc.	February 14, 2022	714,120	2.2%
TELA Bio, Inc.	February 14, 2022	564,120	3.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings

Type	Filed
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
13F-HR	2024-02-13
SC 13D/A	2023-12-29

View PURA VIDA INVESTMENTS, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

The reported total value is incorrect (842148000.0 != 842147000.0)
The reported has been restated
The reported has been amended

Export PURA VIDA INVESTMENTS, LLC's holdings